National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Endometrial Cancer: Prevention, Genetics, Causes
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

New Study of Targeted Therapies for Breast Cancer

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Prevention
Endometrial Cancer Prevention (PDQ®)
[ patient ] [ health professional ]
Expert-reviewed information summary about factors that may influence the risk of developing endometrial cancer and about research aimed at the prevention of this disease.

Clinical Trials to Prevent Endometrial Cancer
Check for endometrial cancer prevention trials from NCI's PDQ® Cancer Clinical Trials Registry now accepting patients. The list of clinical trials can be refined by location, stage of disease, drug, and other features.
Genetics
Understanding Gene Testing
Illustrates what genes are, explains how mutations occur and are identified within genes, and discusses the benefits and limitations of gene testing for cancer and other disorders.

Search: Cancer Genetics Services Directory
Directory of professionals who provide services related to cancer genetic risk assessment, counseling, and testing.

Cancer Genetics Overview (PDQ®)
[ health professional ]
Expert-reviewed information summary in which the validity and utility of genetic tests are discussed and important genetic terms are defined.
Causes and Risk Factors
Oral Contraceptives and Cancer Risk: Questions and Answers
A fact sheet about research on the risk of developing cancer of the breast, cervix, liver, and ovary from the use of oral contraceptives. National Cancer Institute Fact Sheet 3.13

Tamoxifen: Questions and Answers
A fact sheet that describes the action, risks, benefits, and side effects of tamoxifen, a drug that interrupts the hormone estrogen and its connection to breast cancer. National Cancer Institute Fact Sheet 7.16

The Study of Tamoxifen and Raloxifene (STAR): Questions and Answers
STAR is a clinical trial designed to see how the drug raloxifene compares with the drug tamoxifen in reducing the incidence of breast cancer in postmenopausal women who are at an increased risk of developing the disease.

Menopausal Hormone Use: Questions and Answers
Information from the National Heart, Lung, and Blood Institute's Web site. Menopausal hormone use usually involves treatment with either estrogen alone or estrogen in combination with progesterone or progestin.

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov